Himalaya Nutravedics IPO
Updated 16 Sept 2026, 6:45 pm.
Minimum investment (Individual investors (IND))
₹2,54,400
2 lots · 2,400 shares at the upper price band
Price band
₹106
Latest GMP
₹0
0.0% of the ₹106 upper band
Est. listing price
₹0
Issue size
₹26.5 Cr
GMP history
Each point is a recorded observation from the scheduled data sync.
| Observed | GMP | Est. listing price |
|---|---|---|
| 16 Sept 2026, 6:45 pm | ₹0 | ₹0 |
| 16 Sept 2026, 1:45 pm | ₹0 | ₹0 |
GMP is an unofficial, unregulated grey-market estimate — not a prediction of listing performance.
Issue details
- Board
- SME
- Price band
- ₹106
- Issue size
- ₹26.5 Cr
- Lot size
- 1,200
- Opens
- 22 Sept 2026
- Closes
- 24 Sept 2026
- Allotment
- 25 Sept 2026
- Listing
- 29 Sept 2026
- Est. listing price
- ₹0
- Listing price
- Awaited
- Listing gain
- Awaited
- Registrar
- Kfin Technologies Ltd.
- Minimum investment
- ₹2,54,400 (2 lots · 2,400 shares)
- Face value
- ₹10 per share
- Issue type
- Bookbuilding IPO
- Sale type
- Fresh capital only
- Fresh issue
- ₹26 Cr
- Listing at
- BSE SME
- Refunds
- 28 Sept 2026
- Shares credited
- 28 Sept 2026
- Promoter holding
- 95.14% before · 69.94% after
- Lead managers
- Nirbhay Capital Services Pvt.Ltd.
Offer documents & links
Full issue details
Details as published for this issue, read 16 Sept 2026, 9:05 am. Verify against the RHP before applying.
IPO Details
| IPO Date | 22 to 24 Sep, 2026 |
|---|---|
| Listing Date | Tue, Sep 29, 2026 T |
| Face Value | ₹ 10 per share |
| Price Band | ₹100 to ₹106 |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 24,99,600 shares (agg. up to ₹ 26 Cr) |
|---|---|
| Fresh Issue | 24,99,600 shares (agg. up to ₹ 26 Cr) |
| Share Holding Pre Issue | 63,06,720 shares |
| Share Holding Post Issue | 88,06,320 shares |
IPO Timetable (Tentative)
- IPO Open
- Tue, Sep 22, 2026
- IPO Close
- Thu, Sep 24, 2026
- Allotment
- Fri, Sep 25, 2026
- Refund
- Mon, Sep 28, 2026
- Credit of Shares
- Mon, Sep 28, 2026
- Listing
- Tue, Sep 29, 2026
Issue Reservation
| Investor Category | Shares |
|---|---|
| QIB | Not more than 50% of the Net Offer |
| Retail | Not less than 35% of the Net Offer |
| NII | Not less than 15% of the Net Offer |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 2400 | ₹2,54,400 |
| Individual investors (IND) (Max) | 2 | 2400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9600 | ₹10,17,600 |
Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof.
IPO Subscription Details
About Himalaya Nutravedics India Ltd.
Incorporated in June 2022, Himalaya Nutravedics India Limited is a Hyderabad-based Ayurvedic and nutraceutical manufacturing company engaged in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products including Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The company markets its branded products through healthcare practitioners and also undertakes third-party contract manufacturing. It has expanded its presence across 17 states and one union territory in India. Its manufacturing facility is located in Hyderabad, Telangana, and holds ISO 22000:2018, ISO 9001:2015, and WHO-GMP certifications. As of April 30, 2026, the company had 80 employees.
Competitive Strengths :
Integrated multi-dosage manufacturing capability
Doctor acceptance supported by product performance rather than mass advertising
Long-standing relationships with suppliers and customers
Geographic expansion over a short operating history
Broad therapeutic coverage across Ayurvedic and nutraceutical segments
Company Financials (Restated Consolidated)
Total Income
Profit After Tax
EBITDA
NET Worth
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 24.42 | 10.82 | 6.09 |
| Total Income | 43.12 | 21.00 | 14.43 |
| Profit After Tax | 7.39 | 2.23 | 0.43 |
| EBITDA | 8.10 | 2.99 | 0.94 |
| NET Worth | 16.38 | 6.75 | 1.34 |
| Reserves and Surplus | 10.07 | 2.76 | 0.53 |
| Total Borrowing | 5.13 | 1.76 | 3.24 |
| Amount in ₹ Crore |
Himalaya Nutravedics India Ltd.'s revenue increased by 105% and profit after tax (PAT) rose by 231% between the financial year ending with March 31, 2026 and March 31, 2025.
Recently Listed IPOs in Other Food Products
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Elfin Agro India Ltd. | SME | ₹25.03 Cr | ₹47 | 13.05 | ₹47.60 | +1.28% | ₹93.90 |
| Shyam Dhani Industries Ltd. | SME | ₹38.49 Cr | ₹70 | 13.19 | ₹139.65 | +99.50% | ₹52.10 |
| Pajson Agro India Ltd. | SME | ₹74.45 Cr | ₹118 | 10.11 | ₹130.20 | +10.34% | ₹212.00 |
| Mother Nutri Foods Ltd. | SME | ₹39.59 Cr | ₹117 | 17.78 | ₹124.30 | +6.24% | ₹163.05 |
| Rukmani Devi Garg Agro Impex Ltd. | SME | ₹23.52 Cr | ₹99 | 8.5 | ₹77.13 | -22.09% | ₹150.50 |
| Gujarat Peanut & Agri Products Ltd. | SME | ₹23.81 Cr | ₹80 | 8.97 | ₹67.20 | -16.00% | ₹73.00 |
| Orkla India Ltd. | Mainboard | ₹1,667.33 Cr | ₹730 | 39.11 | ₹713.65 | -2.24% | ₹582.30 |
View More »
IPO Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding Working Capital Requirements | 13.75 |
| 2 | Business Development and Digital Marketing Activities | 7.50 |
| 3 | General Corporate Purposes | — |
| Total | 21.25 |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
Key Performance Indicator (KPI)
| KPI | Mar 31, 2026 |
|---|---|
| ROE | 63.87% |
| ROCE | 36.41% |
| Debt/Equity | 0.31 |
| RoNW | 45.12% |
| PAT Margin | 17.16% |
| EBITDA Margin | 18.82% |
| NAV | 26.70 |
| Price to Book Value | 3.97 |
Check IPO Peer Comparison here.
IPO Valuation
| Valuation Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 11.72 | 8.39 |
| P/E (x) | 9.04 | 12.63 |
| Market Cap at Offer Price | ₹66.85 Cr. | ₹93.35 Cr |
Disclaimer
The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2026 available in RHP.
The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2026 available in RHP.
Shareholding Structure
Pre IPO
- Promoter and Promoter Group95.14%
- Public4.86%
Post IPO
- Promoter and Promoter Group69.94%
- Public30.06%
| Category | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 95.14% | 69.94% |
| Public | 4.86% | 30.06% |
| Total | 100% | 100% |
Company Promoters: Rohit Asawa, Divya Asawa, Chanda Asawa and Rama Raju Penmatsas.
Himalaya Nutravedics IPO Recommendations
| Review By | Subscribe | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Brokers | 0 | 0 | 0 | 0 |
| Members | 0 | 0 | 0 | 0 |
IPO Registrar
Kfin Technologies Ltd.
040-79615565
himalaya.ipo@kfintech.com
IPO Lead Manager(s)
Nirbhay Capital Services Pvt.Ltd.
Contact Details
Himalaya Nutravedics India Ltd. Address
Plot No. 101/A, Phase-III,
Industrial Development Park,
Cherlapally, Hindustan Cables Ltd, Uppal
Hyderabad, Telangana , 500051
+91-9063498493
info@himalayanutravedics.com
Himalaya Nutravedics IPO in the news
Recent coverage in the financial press. Headlines are the publishers' own; verify details with the RHP.
No coverage found yet.
